IP Library Granted Patent US 8,207,329
Granted Patent B2
US 8,207,329 · App. 12/095,435 · Granted Jun 26, 2012

Synthesis of chlorins and phorbines with enhanced red spectral features

Assignee: North Carolina State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,207,329
App. No.
12/095,435
Granted
Jun 26, 2012
Kind
B2
Abstract

The present invention provides compounds of the general Formula DI: along with methods of making such compounds, formulations containing the same, and methods of using the same (e.g., in photodynamic therapy, for the production of solar cells, etc.).

Claims (34)

1. A compound of Formula DII:

wherein:

M is a metal or is absent;

X 1 , X 2 , X 3 and X 4 are each independently selected from the group consisting of Se, NH, CH 2 , O and S;

Z is halo;

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 21 , R 22 , R 31 and R 32 are each independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, acyl, formyl, carboxylic acid, acylamino, ester, amide, hydroxyl, nitro, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acyloxy, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, protein, peptide, antibody, nucleic acid, and polyalkylene oxide;

wherein each pair of R 1 and R 2 , R 3 and R 4 , R 11 and R 12 , R 13 and R 14 , R 21 and R 22 , or R 31 and R 32 , can together form ═O;

wherein R 2 and R 3 can together form a double bond; and R 12 and R 13 can together form a double bond;

and wherein each of R 1 and R 2 , R 3 and R 4 , R 11 and R 12 , or R 13 and R 14 , can together form spiroalkyl.

2. The compound of claim 1 , wherein R 31 and R 32 are each independently H, alkyl, or aryl;

or one of R 31 and R 32 is H and the other is cyano;

or one of R 31 and R 32 is H and the other is ester.

3. The compound of claim 1 , wherein R 31 and R 32 are each independently H or alkyl.

4. A compound of Formula DII:

wherein:

M is a metal or is absent;

X 1 , X 2 , X 3 and X 4 are each independently selected from the group consisting of Se, NH, CH 2 , O and S;

Z is halo;

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 21 , R 22 , R 31 and R 32 are each independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, aryloxy, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, acyl, formyl, carboxylic acid, acylamino, ester, amide, hydroxyl, nitro, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acyloxy, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, aminoacyloxy, groups, bioconjugatable groups, targeting groups, and water soluble groups protein, peptide, antibody, nucleic acid, and polyalkylene oxide;

wherein each pair of R 1 and R 2 , R 3 and R 4 , R 11 and R 12 , R 13 and R 14 , R 21 and R 22 , or R 31 and R 32 , can together form ═O;

wherein R 2 and R 3 can together form a double bond; and R 12 and R 13 can together form a double bond;

and wherein each of R 1 and R 2 , R 3 and R 4 , R 11 and R 12 , or R 13 and R 14 , can together form spiroalkyl;

and subject to the proviso that: (i) at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 21 , R 22 , R 31 and R 32 is a group of the Formula:

wherein R a and R b are each an independently selected ionic group, polar group, bioconjugatable group, or targeting group, and Alk a and Alk b are each an independently selected C1-C50 alkylidene chain; or (ii) at least one pair of R 11 and R 12 , R 13 and R 14 , R 21 and R 22 , and R 23 and R 24 are both independently selected Alk′R′, wherein Alk′ is a C1-C50 alkylidene chain, and R is protein, peptide, antibody, nucleic acid, or polyalkylene oxide.

5. The compound of claim 1 , wherein each said cycloalkyl, aryl, heterocyclo, aryl, and heteroaryl, independently or as a part of another group, is independently selected from the group consisting of:

azulenyl, indanyl, indenyl, naphthyl, phenyl, tetrahydronaphthyl,

cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl,

azetidine, azepine, aziridine, diazepine, 1,3-dioxolane, dioxane, dithiane, furan, imidazole, imidazoline, imidazolidine, isothiazole, isothiazoline, isothiazolidine, isoxazole, isoxazoline, isoxazolidine, morpholine, oxadiazole, oxadiazoline, oxadiazolidine, oxazole, oxazoline, oxazolidine, piperazine, piperidine, pyran, pyrazine, pyrazole, pyrazoline, pyrazolidine, pyridine, pyrimidine, pyridazine, pyrrole, pyrroline, pyrrolidine, tetrahydrofuran, tetrahydrothiophene, tetrazine, tetrazole, thiadiazole, thiadiazoline, thiadiazolidine, thiazole, thiazoline, thiazolidine, thiophene, thiomorpholine, thiomorpholine sulfone, thiopyran, triazine, triazole, trithiane,

benzimidazole, benzothiazole, benzothiadiazole, benzothiophene, benzoxadiazole, benzoxazole, benzofuran, benzopyran, benzothiopyran, benzodioxine, 1,3-benzodioxole, cinnoline, indazole, indole, indoline, indolizine, naphthyridine, isobenzofuran, isobenzothiophene, isoindole, isoindoline, isoquinoline, phthalazine, purine, pyranopyridine, quinoline, quinolizine, quinoxaline, quinazoline, tetrahydroisoquinoline, tetrahydroquinoline, and thiopyranopyridine.

6. The compound of claim 4 , wherein each said cycloalkyl, aryl, heterocyclo, aryl, and heteroaryl, independently or as a part of another group, is independently selected from the group consisting of:

azulenyl, indanyl, indenyl, naphthyl, phenyl, tetrahydronaphthyl,

cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl,

azetidine, azepine, aziridine, diazepine, 1,3-dioxolane, dioxane, dithiane, furan, imidazole, imidazoline, imidazolidine, isothiazole, isothiazoline, isothiazolidine, isoxazole, isoxazoline, isoxazolidine, morpholine, oxadiazole, oxadiazoline, oxadiazolidine, oxazole, oxazoline, oxazolidine, piperazine, piperidine, pyran, pyrazine, pyrazole, pyrazoline, pyrazolidine, pyridine, pyrimidine, pyridazine, pyrrole, pyrroline, pyrrolidine, tetrahydrofuran, tetrahydrothiophene, tetrazine, tetrazole, thiadiazole, thiadiazoline, thiadiazolidine, thiazole, thiazoline, thiazolidine, thiophene, thiomorpholine, thiomorpholine sulfone, thiopyran, triazine, triazole, trithiane,

benzimidazole, benzothiazole, benzothiadiazole, benzothiophene, benzoxadiazole, benzoxazole, benzofuran, benzopyran, benzothiopyran, benzodioxine, 1,3-benzodioxole, cinnoline, indazole, indole, indoline, indolizine, naphthyridine, isobenzofuran, isobenzothiophene, isoindole, isoindoline, isoquinoline, phthalazine, purine, pyranopyridine, quinoline, quinolizine, quinoxaline, quinazoline, tetrahydroisoquinoline, tetrahydroquinoline, and thiopyranopyridine.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 27, 2017
From: NORTH CAROLINA STATE UNIVERSITY RALEIGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042352/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2009
From: LINDSEY, JONATHAN S.; LAHA, JOYDEV K.; CHINNASAMY, MUTHIAH; BORBAS, K. ESZTER
To: NORTH CAROLINA STATE UNIVERSITY
Reel/Frame 022180/0681 →
Continuity (2)
Provisional Application 60740924 · Nov 30, 2005
Related Publication 20090227553A1 · Sep 10, 2009